CClinicalTrials.gg
CompletedNCT05735353Updated Sep 28, 2023

Sleep, Diet, Exercise and Older Persons

An interventional study of High-Speed Circuit Resistance Training and High-Speed Multidirectional Yoga in Cognitive Change and Cognitive Decline, sponsored by University of Miami. Completed at 1 site in United States. Open to participants aged 60 Years to 99 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2023-09-28.

Sponsored by University of Miami · Not applicable, Interventional, and Treatment

Phase
Not applicable
Study type
Interventional
Enrollment
40
Allocation
Randomized
Ages
60 Years to 99 Years
Sex
All
01

Study summary

To examine the impacts of a cognitive yoga program and circuit resistance training on cognitive and physical performance with nutrition and sleep as modulating factors in healthy, older adults.

02

Conditions studied

  • Cognitive Change
  • Cognitive Decline

Keywords

  • Circuit Resistance Training
  • Yoga
  • Cognition
03

In context

Cognitive Dysfunction

3,843 studies on the registry are indexed under Cognitive Dysfunction; 1,100 are open to participants now.

This study's enrollment of 40 is below the median of 65 across 2,808 interventional studies indexed under Cognitive Dysfunction.

Browse Cognitive Dysfunction studies →

Lead sponsor

University of Miami is the lead sponsor of 820 studies on the registry; 161 are open to participants now.

Of its 111 completed or terminated interventional studies of FDA-regulated products, 93 (84%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
60 Years to 99 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Inclusion criteria

  • Montreal Cognitive Assessment > 23
  • No memory loss complaints

Exclusion criteria

Exclusion Criteria:

  • Uncontrolled cardiovascular or neuromuscular disease that prevents participation in a training program
  • Musculoskeletal impairments or injury that may impact exercise participation
  • Visual or hearing impairments
  • Neurological disease
  • Stroke
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
40 participants (actual)

Study arms

  • Experimental
    High-Speed Circuit Resistance Training Group

    Participants in this group will receive high-speed circuit resistance training for 12 consecutive weeks.

    Behavioral: High-Speed Circuit Resistance Training

  • Experimental
    High-Speed Multidirectional Yoga Group

    Participants in this group will receive high-speed multidirectional yoga for 12 consecutive weeks.

    Behavioral: High-Speed Multidirectional Yoga

Interventions

  • BehavioralHigh-Speed Circuit Resistance Training

    three times per week; 45 minutes per session; 12-weeks

  • BehavioralHigh-Speed Multidirectional Yoga

    two times per week; 60 minutes per session; 12-weeks

06

What researchers measure

Primary outcomes

  1. Changes in Executive Function

    Changes in executive function composite score measured by the NIH Toolbox Cognition Module

    Time frame: Baseline, 16 weeks

Secondary outcomes

  1. Changes in Nutritional Status

    Nutritional status will be assessed by the Nutritionist Pro (Axxya Systems, Redmond, WA), a nutrition analysis software that can be used for diet 24 hour recalls. Participants will be asked to recall food intake for one weekday and one weekend day.

    Time frame: Baseline, 16 weeks.

  2. Changes in Sleep Quality as measured by the Pittsburg Sleep Quality Index

    The Pittsburg Sleep Quality Index has seven component scores that are added to yield one global score, with a range of 0-21 points, "0" indicating no difficulty and "21" indicating severe difficulties in all areas.

    Time frame: Baseline, 16 weeks.

07

Study locations

1 site
  • Laboratory of Neruomuscular Research and Active Aging
    Coral Gables, Florida 33147, United States
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Sep 28, 2023, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT05735353
Lead sponsor
University of Miami
Responsible party
Joseph Signorile (Professor, University of Miami) — Principal investigator
First posted
Feb 21, 2023
Start date
Jan 17, 2023
Primary completion
Jul 30, 2023
Completion
Jul 30, 2023
Last update
Sep 28, 2023

Study contacts

Joseph Signorile, PhD
principal investigator · University of Miami

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Apr 2023. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion